Strengthening the understanding of the relationship between survival designs and test statistics.
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 2, p. 113, doi. 10.1002/pst.381
- By:
- Publication type:
- Article
Works matching IS 15391604 AND DT 2010 AND VI 9 AND IP 2
Results: 9
1
2
Literature Review January-March 2010.
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 2, p. 168, doi. 10.1002/pst.437
- By:
- Publication type:
- Article
3
Sample size considerations for Japanese patients in a multi-regional trial based on MHLW guidance.
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 2, p. 100, doi. 10.1002/pst.380
- By:
- Publication type:
- Article
4
Impact of missing data on type 1 error rates in non-inferiority trials.
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 2, p. 87, doi. 10.1002/pst.378
- By:
- Publication type:
- Article
5
Nonparametric equivalence testing with respect to the median difference.
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 2, p. 142, doi. 10.1002/pst.384
- By:
- Publication type:
- Article
6
Empirical Bayes models of Poisson clinical trials and sample size determination.
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 2, p. 133, doi. 10.1002/pst.383
- By:
- Publication type:
- Article
7
A note on the Hodges-Lehmann estimator.
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 2, p. 162, doi. 10.1002/pst.387
- By:
- Publication type:
- Article
8
Sample size calculation for an agreement study.
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 2, p. 125, doi. 10.1002/pst.382
- By:
- Publication type:
- Article
9
The application of bespoke spending functions in group-sequential designs and the effect of delayed treatment switching in survival trials.
- Published in:
- Pharmaceutical Statistics, 2010, v. 9, n. 2, p. 151, doi. 10.1002/pst.386
- By:
- Publication type:
- Article